Health Care | Health Care Equipment & Services | Health Care Equipment & Supplies | Health Care Equipment
NYSE | Common Stock
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system.
The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system.
In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces.
Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers.
The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons.
The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022.
Artivion Inc. was founded
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 4, 21 | 0.26 Increased by +425.00% | -0.02 Increased by +1.40 K% |
| Jul 29, 21 | -0.06 Increased by +40.00% | -0.05 Decreased by -20.00% |
| Apr 29, 21 | -0.08 Increased by +55.56% | -0.09 Increased by +14.26% |
| Feb 11, 21 | -0.09 Decreased by -350.00% | -0.04 Decreased by -100.00% |
| Nov 4, 20 | -0.08 Decreased by -233.33% | -0.09 Increased by +13.51% |
| Jul 30, 20 | -0.10 Decreased by -242.86% | -0.17 Increased by +42.86% |
| Apr 30, 20 | -0.18 Decreased by -1.70 K% | -0.07 Decreased by -176.92% |
| Feb 13, 20 | -0.02 Increased by +60.00% | 0.03 Decreased by -170.67% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 22 | 77.21 M Increased by +8.62% | -3.39 M Decreased by -8.00% | Decreased by -4.39% Increased by +0.57% |
| Dec 31, 21 | 79.39 M Increased by +16.93% | -20.10 M Decreased by -481.26% | Decreased by -25.32% Decreased by -397.08% |
| Sep 30, 21 | 72.21 M Increased by +10.86% | 10.58 M Increased by +468.71% | Increased by +14.66% Increased by +432.58% |
| Jun 30, 21 | 76.15 M Increased by +41.62% | -2.18 M Increased by +40.96% | Decreased by -2.86% Increased by +58.31% |
| Mar 31, 21 | 71.09 M Increased by +7.01% | -3.14 M Increased by +52.92% | Decreased by -4.41% Increased by +56.00% |
| Dec 31, 20 | 67.90 M Decreased by -2.58% | -3.46 M Decreased by -407.78% | Decreased by -5.09% Decreased by -421.25% |
| Sep 30, 20 | 65.13 M Decreased by -4.05% | -2.87 M Decreased by -2.04 K% | Decreased by -4.41% Decreased by -2.13 K% |
| Jun 30, 20 | 53.77 M Decreased by -24.41% | -3.69 M Decreased by -230.26% | Decreased by -6.86% Decreased by -272.34% |